These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 11431140

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
    Bodek G, Vierre S, Rivero-Müller A, Huhtaniemi I, Ziecik AJ, Rahman NA.
    Neoplasia; 2005 May; 7(5):497-508. PubMed ID: 15967102
    [Abstract] [Full Text] [Related]

  • 23. Indirect Sertoli cell-mediated ablation of germ cells in mice expressing the inhibin-alpha promoter/herpes simplex virus thymidine kinase transgene.
    Ahtiainen M, Toppari J, Poutanen M, Huhtaniemi I.
    Biol Reprod; 2004 Nov; 71(5):1545-50. PubMed ID: 15240419
    [Abstract] [Full Text] [Related]

  • 24. Local regression of breast tumors following intramammary ganciclovir administration in double transgenic mice expressing neu oncogene and herpes simplex virus thymidine kinase.
    Sacco MG, Mangiarini L, Villa A, Macchi P, Barbieri O, Sacchi MC, Monteggia E, Fasolo V, Vezzoni P, Clerici L.
    Gene Ther; 1995 Sep; 2(7):493-7. PubMed ID: 7584128
    [Abstract] [Full Text] [Related]

  • 25. Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir.
    Macri P, Gordon JW.
    Hum Gene Ther; 1994 Feb; 5(2):175-82. PubMed ID: 7514448
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR, Kittaka M, Gordon EM, Gray B, Stins MF, McComb JG, Jovanovic S, Tabrizi P, Weiss MH, Bartus R, Anderson WF, Zlokovic BV.
    Hum Gene Ther; 1998 May 01; 9(7):989-95. PubMed ID: 9607410
    [Abstract] [Full Text] [Related]

  • 30. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
    Vlachaki MT, Chhikara M, Aguilar L, Zhu X, Chiu KJ, Woo S, Teh BS, Thompson TC, Butler EB, Aguilar-Cordova E.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):1008-17. PubMed ID: 11704325
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Recombinant interferon alpha2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase system.
    Whartenby KA, Darnowski JW, Freeman SM, Yurasha K, Calabresi P.
    Cancer Gene Ther; 1999 Nov 15; 6(5):402-8. PubMed ID: 10505850
    [Abstract] [Full Text] [Related]

  • 33. Herpes simplex virus thymidine kinase and ganciclovir suicide gene therapy for human pancreatic cancer.
    Wang J, Lu XX, Chen DZ, Li SF, Zhang LS.
    World J Gastroenterol; 2004 Feb 01; 10(3):400-3. PubMed ID: 14760766
    [Abstract] [Full Text] [Related]

  • 34. Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy.
    Ramesh R, Munshi A, Marrogi AJ, Freeman SM.
    Int J Cancer; 1999 Jan 29; 80(3):380-6. PubMed ID: 9935178
    [Abstract] [Full Text] [Related]

  • 35. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
    Hayashi K, Hayashi T, Sun HD, Takeda Y.
    Cancer Gene Ther; 2000 Jan 29; 7(1):45-52. PubMed ID: 10678355
    [Abstract] [Full Text] [Related]

  • 36. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y, Ohtsuru A, Kaneda Y, Nagayama Y, Kawazoe Y, Eguchi S, Kuroda H, Fujioka H, Ito M, Kanematsu T, Yamashita S.
    Hum Gene Ther; 1999 Jun 10; 10(9):1509-19. PubMed ID: 10395376
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene.
    Li BJ, Zhang C, Yi YX, Hao Y, Liu XP, Ou QJ.
    World J Gastroenterol; 2007 Aug 07; 13(29):4006-10. PubMed ID: 17663519
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.